QuidelOrtho to Participate in Three Upcoming Investor Conferences
28 Ottobre 2024 - 12:00PM
Business Wire
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or
“QuidelOrtho”), a global provider of innovative in vitro diagnostic
technologies designed for point-of-care settings, clinical labs and
transfusion medicine, announced today that members of its
management team will attend three upcoming investor conferences and
participate in fireside chats at all three conferences.
UBS Global Healthcare Conference On Tuesday, November 12,
2024, QuidelOrtho is scheduled to participate in a fireside chat at
2:00 p.m. ET / 11:00 a.m. PT at the conference in Rancho Palos
Verdes, California.
Citi 2024 Global Healthcare Conference On Wednesday,
December 4, 2024, QuidelOrtho is scheduled to participate in a
fireside chat at 1:00 p.m. ET / 10:00 a.m. PT at the conference in
Miami, Florida.
Evercore ISI 7th Annual HealthConX Conference On
Thursday, December 5, 2024, QuidelOrtho is scheduled to participate
in a fireside chat at 10:00 a.m. ET / 7:00 a.m. PT at the
conference in Coral Gables, Florida.
Interested parties can access the live webcasts and replays of
the events in the “Events & Presentations” section of the
“Investor Relations” page of QuidelOrtho’s website at
https://ir.quidelortho.com/.
QuidelOrtho is dedicated to advancing diagnostics to power a
healthier future. For more information, please visit
quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and
X.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in
vitro diagnostics, developing and manufacturing intelligent
solutions that transform data into understanding and action for
more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular
testing, clinical chemistry and transfusion medicine, bringing
fast, accurate and reliable diagnostics when and where they are
needed – from home to hospital, lab to clinic. So that patients,
clinicians and health officials can spot trends sooner, respond
quicker and chart the course ahead with accuracy and
confidence.
Building upon its many years of groundbreaking innovation,
QuidelOrtho continues to partner with customers across the
healthcare continuum and around the globe to forge a new diagnostic
frontier. One where insights and solutions know no bounds,
expertise seamlessly connects and a more informed path is
illuminated for each of us.
Source: QuidelOrtho Corporation
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241028721746/en/
Investor Contact: Juliet Cunningham Vice President, Investor
Relations IR@QuidelOrtho.com
Media Contact: D. Nikki Wheeler Senior Director, Corporate
Communications media@QuidelOrtho.com
Grafico Azioni QuidelOrtho (NASDAQ:QDEL)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni QuidelOrtho (NASDAQ:QDEL)
Storico
Da Dic 2023 a Dic 2024